The Clorox Company (NYSE:CLX) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. cut its stake in The Clorox Company (NYSE:CLX - Free Report) by 19.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,866 shares of the company's stock after selling 3,091 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Clorox were worth $2,090,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Wealthcare Advisory Partners LLC grew its position in shares of Clorox by 22.4% during the 4th quarter. Wealthcare Advisory Partners LLC now owns 1,590 shares of the company's stock valued at $258,000 after acquiring an additional 291 shares during the period. Merit Financial Group LLC boosted its position in Clorox by 17.3% during the fourth quarter. Merit Financial Group LLC now owns 2,274 shares of the company's stock worth $369,000 after purchasing an additional 336 shares in the last quarter. HB Wealth Management LLC boosted its position in Clorox by 12.4% during the fourth quarter. HB Wealth Management LLC now owns 4,588 shares of the company's stock worth $745,000 after purchasing an additional 506 shares in the last quarter. Aaron Wealth Advisors LLC acquired a new stake in Clorox in the fourth quarter valued at approximately $242,000. Finally, ZWJ Investment Counsel Inc. increased its position in shares of Clorox by 6.6% in the fourth quarter. ZWJ Investment Counsel Inc. now owns 1,918 shares of the company's stock valued at $312,000 after buying an additional 118 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CLX. Royal Bank of Canada reiterated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. UBS Group decreased their price objective on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a report on Thursday, April 17th. Wells Fargo & Company dropped their target price on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a research report on Tuesday, May 6th. Finally, Evercore ISI set a $140.00 price target on shares of Clorox and gave the company an "underperform" rating in a research note on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $151.23.

Insiders Place Their Bets

In other news, Director Pierre R. Breber purchased 4,000 shares of the company's stock in a transaction dated Wednesday, May 7th. The stock was acquired at an average price of $136.57 per share, with a total value of $546,280.00. Following the purchase, the director now directly owns 4,000 shares in the company, valued at approximately $546,280. This represents a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 0.57% of the stock is owned by insiders.

Clorox Price Performance

Shares of NYSE:CLX traded down $0.11 during midday trading on Tuesday, hitting $130.77. The company had a trading volume of 210,397 shares, compared to its average volume of 1,329,663. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The stock has a market cap of $16.12 billion, a price-to-earnings ratio of 35.72, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The business's 50-day simple moving average is $139.35 and its 200-day simple moving average is $152.00.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The firm's quarterly revenue was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.71 earnings per share. On average, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.